Development of Real-Time Quantitative Polymerase Chain Reaction Assays to Track Treatment Response in Retinoid Resistant Acute Promyelocytic Leukemia

Molecular detection of minimal residual disease (MRD) has become established to assess remission status and guide therapy in patients with ProMyelocytic Leukemia–RARA+ acute promyelocytic leukemia (APL). However, there are few data on tracking disease response in patients with rarer retinoid resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovanovic, Jelena V., Rennie, Kristian, Culligan, Dominic, Peniket, Andrew, Lennard, Anne, Harrison, Justin, Vyas, Paresh, Grimwade, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356041/
https://www.ncbi.nlm.nih.gov/pubmed/22655241
http://dx.doi.org/10.3389/fonc.2011.00035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356041/
https://www.ncbi.nlm.nih.gov/pubmed/22655241
http://dx.doi.org/10.3389/fonc.2011.00035

Ejemplares similares